Calabria Dominick A MD is categorized under Cardiologists in Bradenton, FL and active since 1995.
Calabria Dominick A MD was established in 1995, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Cardiologists business, which does work in the B2C market, and is classified as a Cardiologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Dominick Calabria at the company’s single location by writing to 6100 Pointe West Boulevard, Bradenton, Florida FL 34209 or by phoning (941) 792-1717. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Calabria Dominick A MD |
| Contact Person: | Dominick Calabria |
| Address: | 6100 Pointe West Boulevard, Bradenton, Florida 34209 |
| Phone Number: | (941) 792-1717 |
| Website Address: | myfloridaveincenter.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Cardiologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Calabria Dominick A MD was started in 1995 to provide professional Cardiologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Dominick Calabria for inquiries that concern Calabria Dominick A MD by calling the company number (941) 792-1717, as your correspondence is most welcome. Additionally, the physical location of the single location of Calabria Dominick A MD can be found at the coordinates 27.47959,-82.62287 as well as the street address 6100 Pointe West Boulevard in Bradenton, Florida 34209.
For its online presence, you may visit Calabria Dominick A MD’s website at myfloridaveincenter.com and engage with its social media outlets through on Twitter and on Facebook.